Pendium
BioAge Labs
BioAge Labs
Visibility32
Vibe98
Businesses/Biotechnology & Pharmaceuticals/BioAge Labs
BioAge Labs
AI Visibility & Sentiment

BioAge Labs

BioAge Labs is a biotechnology company harnessing the biology of human aging to develop new therapies for metabolic diseases. They utilize a proprietary multi-omics discovery platform to identify molecular mediators of aging and disease, with lead programs targeting cardiovascular risk and metabolic dysfunction.

Active Monitoring
bioagelabs.com
Biotechnology & Pharmaceuticals
AI Visibility Score
32/100

Low

Sentiment Score
98/100
AI Perception

Summary

BioAge Labs is an undisputed leader in AI-driven multi-omics discovery, commanding a flawless 100% mention rate on ChatGPT and dominating Google AI Overviews for category leadership. Despite this technical authority, a massive intelligence gap exists as the brand remains largely invisible to Claude and Gemini users, missing critical representation in the metabolic and obesity research narratives.

Value Proposition

Pioneering therapies that address the root cause of metabolic diseases by targeting the biology of human aging, using decades of multi-omics data to identify novel therapeutic pathways

Overview

BioAge Labs is a biotechnology company harnessing the biology of human aging to develop new therapies for metabolic diseases. They utilize a proprietary multi-omics discovery platform to identify molecular mediators of aging and disease, with lead programs targeting cardiovascular risk and metabolic dysfunction.

Mission

Harnessing the biology of human aging to develop transformative therapies for metabolic diseases

Products & Services
BGE-102 NLRP3 anti-inflammatory therapy for cardiovascular riskAPJ agonist for enhanced weight loss and body compositionHuman-first multi-omics discovery platformPipeline programs targeting metabolic aging pathways
Agent Breakdown

AI Platforms

How often do different AI platforms reference BioAge Labs?

Loading explorer...
Conversation Analysis

Topics

What conversations is BioAge Labs included in — or excluded from?

Loading explorer...
Buyer Personas

Personas

Who does each AI platform recommend BioAge Labs to, and when?

Loading explorer...
Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT
Claude
Gemini
AI Overviews

Metabolic and Longevity Investment Analysis

2 queries
“summarize the current landscape of longevity biotechs for a venture capital firm, who are the leaders in metabolic aging?”
ChatGPT
Claude
Gemini
AI Overviews
1/4
“identify top biotech companies working on therapies for aging-related diseases, specifically targeting inflammation and metabolism”
ChatGPT
Claude
Gemini
AI Overviews
1/4

Next-Gen Obesity and Cardiovascular Research

2 queries
“find me promising drug candidates for weight loss that focus on body composition and muscle preservation beyond glp-1s, specific therapies to watch please”
ChatGPT
Claude
Gemini
AI Overviews
1/4
“what are the newest nlrp3 inhibitors in clinical trials for cardiovascular risk and what are their mechanisms?”
ChatGPT
Claude
Gemini
AI Overviews
1/4

Trust & Category Leader Evaluation

2 queries
“which biotechnology companies are actually backed by human-first multi-omics data for aging research, not just mouse models?”
ChatGPT
Claude
Gemini
AI Overviews
1/4
“compare the most credible companies in the longevity space like Altos Labs and Calico, who else is doing serious clinical work?”
ChatGPT
Claude
Gemini
AI Overviews
1/4

AI and Multi-Omics Platform Discovery

2 queries
“who has the best human-first multi-omics platform for identifying novel metabolic disease targets, give me specific company names”
ChatGPT
Claude
Gemini
AI Overviews
1/4
“help me find biotech firms using big data to solve age-related cardiovascular issues, who should I be looking at for a partnership?”
ChatGPT
Claude
Gemini
AI Overviews
1/4
Analysis

Key Insights

What AI visibility analysis reveals about this brand

Strength

Absolute dominance in AI and Multi-Omics Platform Discovery queries, particularly on ChatGPT where it holds the #1 position for human-first platform identification.

Strength

High resonance with technical personas, specifically the Computational Biology Research Lead, achieving a 75% mention rate and an elite 2.7 average position.

Strength

Strong trust signal integration, evidenced by holding the #1 spot in AI Overviews for queries regarding human-first data-backed biotechnology companies.

Gap

Significant underperformance on Claude and Gemini, where mention rates plummet to 25% and 31% respectively, leaving the brand out of critical longevity landscape conversations.

Gap

Poor penetration in the 'Next-Gen Obesity and Cardiovascular Research' segment, failing to appear in several key clinical trial queries for NLRP3 inhibitors.

Gap

Visibility with the Biotech Venture Partner persona is lagging at 38%, indicating that AI models do not yet strongly associate the brand with investment-grade longevity analysis.

Opportunity

Capture the metabolic research narrative by aligning technical content with AI-optimized keywords for weight loss and NLRP3 clinical trials.

Opportunity

Leverage existing dominance in Google AI Overviews to siphon traffic from competitors like Insilico Medicine, who currently hold a higher average position across all platforms.

Opportunity

Target the 'Venture Partner' persona by increasing the volume of public-facing investment-grade data and strategic partnership announcements.

Technical Health

Site Health for AI Visibility

How well BioAge Labs's website is optimized for AI agent discovery and comprehension.

89/100
14 passed 4 warnings
Audited 2/24/2026
Crawlability93

Can AI bots find your pages?

Technical90

SSL, mobile, doctype basics

On-Page SEO82

Titles, descriptions, headings

Content Quality82

Word count, depth, freshness

Schema Markup85

Structured data for AI comprehension

Social & OG100

Open Graph, Twitter cards

AI Readability85

How well AI can parse your content

Warnings

!

No robots.txt file found

Create a robots.txt file at your domain root. Optional but recommended.

!

5 render-blocking resources are slowing initial render

Defer non-critical JS with async/defer. Inline critical CSS. Move stylesheets to load asynchronously.

!

Title is too short (22 characters)

Expand the title to 50-60 characters with descriptive keywords.

!

Meta description may be truncated (202 characters)

Shorten to under 160 characters.

!

Page has 2 H1 tags. Best practice is one.

Use a single H1 for the main heading, and H2-H6 for subheadings.

+ 2 more warnings

Want a full technical audit with AI-specific recommendations?

Run a free visibility scan
Brand Identity

Brand Voice & Style

How AI perceives BioAge Labs's communication style and personality

BioAge Labs communicates with scientific authority and measured confidence, reflecting their position as pioneers in aging biology research. Their tone balances technical sophistication with accessible explanations of complex science. They convey optimism about their therapeutic potential while maintaining the credibility expected of a clinical-stage biotech company. The voice is forward-looking and purposeful, emphasizing their unique approach to understanding human aging.

Core Tone Traits

Scientifically Authoritative

Speaks with deep expertise in aging biology and metabolic disease research

Purposefully Innovative

Emphasizes pioneering approaches and novel therapeutic pathways

Measured & Credible

Balances optimism with scientific rigor and realistic timelines

Forward-Looking

Focuses on future potential and transformative health outcomes

Competitive Landscape

Related Ecosystem

Related products and services that AI mentions in conversations alongside or instead of BioAge Labs

1BioAge Labs41 mentions
2Alphabet18 mentions
3Altos Labs17 mentions
4Unity Biotechnology14 mentions
5Insilico Medicine14 mentions
6Eli Lilly13 mentions
7Novartis11 mentions
8Calico Life Sciences10 mentions
9Elysium Health9 mentions
10Calico9 mentions
11Roche8 mentions
Source Intelligence

Citations

Sources that AI assistants cite. Getting featured here improves visibility.

5 Longevity Startups in Silicon Valley to Watch in 2026

https://innocosevents.com/silicon-valley-startups/#:~:text=Their%20research%20focuses%20on%20epigenetic,5.

Referenced in 1 query

Review
5 Longevity Startups in Silicon Valley to Watch in 2026 - INNOCOS

https://innocosevents.com/silicon-valley-startups/

Referenced in 1 query

Review
Top 20 Most Innovative Longevity Biotechs in the World (2026)

https://www.scispot.com/blog/top-20-of-most-innovative-anti-aging-companies-in-the-world#:~:text=Founded%20in%202021%20and%20backed,Location:%20California%2C%20USA

Referenced in 1 query

Review
The Longevity Boom: Opportunities in Anti-Aging - Gabelli

https://gabelli.com/research/the-longevity-boom-opportunities-in-anti-aging/#:~:text=Unity%20Biotechnology%20(NASDAQ:%20UBX),RF)%2Dbased%20aesthetic%20devices.

Referenced in 1 query

Review
Six Startups Changing The Way We Age - BioSpace

https://www.biospace.com/business/six-startups-changing-the-way-we-age#:~:text=Then%2C%20in%20October%202024%2C%20the,%2C%E2%80%9D%20according%20to%20its%20website.

Referenced in 2 queries

Review
Longevity startups to watch in 2025. + Product ideas - LinkedIn

https://www.linkedin.com/pulse/new-wave-longevity-startups-2025-ideas-your-next-product-orangesoft-ettwf#:~:text=Gene%20and%20%D1%81ell%20therapies%20%E2%80%94%20Some,with%20precision%20and%20predict%20healthspan.

Referenced in 1 query

Pitch Story
13 anti-aging biotech companies leading longevity in 2025

https://www.labiotech.eu/best-biotech/anti-aging-biotech-companies/#:~:text=Altos%20Labs%20has%20attracted%20a,occur%20throughout%20a%20person's%20life.

Referenced in 1 query

Review
The Longevity Bet: Why VCs Are Pouring Capital Into Lifestyle ...

https://www.thelotuscapital.com/the-longevity-bet-why-vcs-are-pouring-capital-into-lifestyle-medicine/#:~:text=Who's%20Investing:%20The%20VC%20Firms,through%20platforms%20like%20Function%20Health.

Referenced in 1 query

Review
Biotech Venture Limped Through 2025. A Brighter 2026 ... - WSJ

https://www.wsj.com/articles/biotech-venture-limped-through-2025-a-brighter-2026-beckons-a53e2efa#:~:text=Venture%20capitalists%20point%20to%20a,Million%20in%20Tech%20Buildout%20Push

Referenced in 1 query

Pitch Story
Can the Comeback Continue? 2026 Biotech Outlook

https://www.mizuhogroup.com/americas-insights/can-the-comeback-continue-2026-biotech-outlook#:~:text=In%202026%2C%20biotech%20remains%20attractive,rally%20may%20be%20short%2Dlived.

Referenced in 1 query

Review
Longevity Investing in 2026: A Strategic Guide for Family Offices

https://www.linkedin.com/pulse/longevity-investing-2026-strategic-guide-family-tm01f#:~:text=2026%20marks%20a%20critical%20inflection,underpinned%20by%20several%20key%20developments:

Referenced in 1 query

Pitch Story
The Billionaires Fueling the Quest for Longer Life - WSJ

https://www.wsj.com/health/wellness/billionaires-longevity-health-04dd205c#:~:text=Investors%20including%20Peter%20Thiel%20and,company%20statements%20and%20regulatory%20filings.

Referenced in 1 query

Pitch Story
Content Engineering

Goals & Content Ideas

Ideas to help AI agents better understand the business and be more likely to use BioAge Labs's resources to help users.

Dominate Claude and Gemini Training Datasets

Address the 70%+ visibility gap between ChatGPT and other major LLMs by executing a targeted scientific PR strategy. This involves publishing structured data, press releases, and technical content through high-authority scientific channels that Anthropic and Google's models prioritize during training updates. Social media will amplify peer-reviewed findings and clinical milestones with schema-optimized formatting.

How BioAge's Multi-Omics Platform Decoded 30 Years of Human Aging Data
The Science Behind Targeting Molecular Mediators of Metabolic Disease
Breaking Down Our Latest Clinical Milestone in Cardiovascular Risk Reduction
What Makes Aging Biology Research Different from Traditional Drug Discovery
Key Findings: How Human Aging Data Reveals Novel Therapeutic Pathways

Capture Next-Gen Obesity Query Visibility

Optimize all digital assets to rank prominently when AI assistants answer queries about next-generation obesity treatments and NLRP3 inhibitors. Create authoritative content positioning BioAge as a leader in cardiovascular research despite competitor presence in these therapeutic areas. Deploy keyword-rich scientific explanations that LLMs can easily parse and cite.

Why NLRP3 Inhibition Could Transform Cardiovascular Disease Treatment
The Connection Between Aging Biology and Next-Generation Obesity Therapies
How Metabolic Dysfunction and Cardiovascular Risk Share Common Molecular Roots
Beyond Weight Loss: Addressing Obesity Through the Lens of Human Aging
What Clinicians Should Know About Emerging NLRP3-Targeted Therapies

Strengthen Investor-Focused Trust Narrative

Address the 38% mention rate vulnerability among biotech venture partners by refining BioAge's category leadership narrative for investor audiences. Create content that positions BioAge as a top-tier longevity investment prospect, ensuring AI models recommend the company when investors ask about promising aging biology companies. Leverage social proof and clinical pipeline updates.

Why Aging Biology Represents the Next Frontier in Biotech Investment
Inside BioAge's Proprietary Discovery Platform: A Competitive Advantage Explained
From Multi-Omics Data to Clinical Trials: Our Path to Therapeutic Innovation
What Sets Clinical-Stage Longevity Companies Apart in Today's Market
The Investment Case for Targeting Root Causes of Metabolic Disease

Outperform Competitor AI Content Strategies

Benchmark and neutralize the content strategies of Insilico Medicine and Calico Life Sciences, who maintain better average AI visibility positions. Analyze their content structures that AI crawlers parse effectively and implement similar formatting while differentiating BioAge's unique multi-omics approach. Create consistently structured content that improves crawlability and citation rates.

How BioAge's Human-Data-First Approach Differs from Computational Drug Discovery
Comparing Approaches: Why Real Human Aging Data Outperforms Synthetic Models
The Advantage of Decades-Long Longitudinal Studies in Therapeutic Development
What Our Proprietary Platform Reveals That AI-Only Approaches Cannot
Clinical Validation: Moving Beyond Computational Predictions to Human Outcomes
Content Engineering

Recommended Actions

!

Execute an LLM-specific data injection strategy targeting Claude and Gemini's training datasets through high-authority scientific PR and structured data.

The 70%+ gap in visibility between ChatGPT and other LLMs suggests BioAge's technical milestones are not being ingested or weighted correctly by Anthropic and Google's models.

Impact: High
!

Optimize digital assets for the 'Next-Gen Obesity' and 'NLRP3 inhibitor' query sets to improve visibility in the cardiovascular research segment.

BioAge is currently losing ground to competitors in these high-value therapeutic areas despite having the underlying platform to lead these conversations.

Impact: High
~

Refine the brand's 'Trust & Category Leader' narrative to specifically target the Biotech Venture Partner persona.

A 38% mention rate among investors is a vulnerability for a VC-backed firm; increasing this will ensure AI models recommend BioAge as a top-tier longevity prospect.

Impact: Medium
~

Benchmark and neutralize the content strategies of Insilico Medicine and Calico Life Sciences.

These competitors maintain more consistent visibility and better average positions (3.6 and 3.7 respectively), suggesting their content is more easily parsed by AI crawlers.

Impact: Medium

Is this your business? We can help you improve your AI visibility.

Book a Free Strategy Sessionor Sign In to Get Started
Backing

Investors

P
Pear VC
Data generated by Pendium.ai AI visibility scanning. Last scanned February 24, 2026.

Start getting recommended by AI

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.